Cashu FinanceCashu Finance
  • Terminal
  • Pulse
  • Spotlight
  • News
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. OTC
  4. BAYRY

Market Cap: $60.32B

BA

Bayer AG

BAYRY
OTC (Other OTC)USD
Invest in BAYRY
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksScreenersAboutAuthorsAdvertisersBrokersConferencesContact

Legal

Terms of ServicePrivacy PolicyEditorial PolicyCorrections Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

News

Bayer AG's Growth Potential from U.S. Defense Production Act Focusing on Herbicide Supply

Bayer AG Poised to Benefit from U.S. Defense Production Act for Herbicides In a decisive move highlighting a shift towards strengthening domestic agricultural production, President Donald Trump signs…

Cashu Finance·9 months ago

U.S. DPA Boost for Glyphosate and Phosphorus Elevates U.S. Supply Stakes for Bayer AG

U.S. DPA move on glyphosate and phosphorus places strategic spotlight on Bayer AG A presidential order invoking the Defense Production Act to boost domestic supplies of elemental phosphorus and glypho…

Cashu Finance·9 months ago

Bayer AG presses $10.5 billion plan to resolve Roundup cancer litigation

Bayer presses $10.5 billion plan to resolve Roundup cancer litigation Bayer AG is pushing a $10.5 billion settlement package to resolve current and future U.S. lawsuits alleging its Roundup weedkiller…

Cashu Finance·9 months ago

Bayer AG proposes $10.5B settlement package to resolve Roundup U.S. cancer lawsuits

Bayer moves to cap Roundup litigation with $10.5 billion settlement package Bayer AG announces a proposed $10.5 billion package to resolve current and future U.S. lawsuits that allege its Roundup weed…

Cashu Finance·9 months ago

Supreme Court review could redefine Roundup liability for Bayer AG

Supreme Court review could redefine Roundup liability for Bayer The U.S. Supreme Court is set to hear Monsanto Co. v. Durnell on April 27, a case that could reshape how liability for glyphosate‑based…

Cashu Finance·9 months ago

Supreme Court to decide whether federal law preempts Roundup failure-to-warn suits against Bayer

Supreme Court to resolve Roundup preemption fight The U.S. Supreme Court is agreeing to hear Monsanto Co. v. Durnell on April 27, setting up a high-stakes test of whether federal pesticide labeling la…

Cashu Finance·9 months ago

Supreme Court to Hear Roundup Liability Appeal Involving Bayer AG

Bayer’s Roundup Appeal Moves to the Supreme Court Supreme Court Takes Up Roundup Liability Fight The U.S. Supreme Court on Feb. 11 announces it will hear Monsanto Co. v. Durnell on April 27, taking di…

Cashu Finance·9 months ago

Market Turbulence Tests Bayer AG's Commodity, Currency and Funding Exposure

Market turbulence tests Bayer’s commodity, currency and funding exposure What the market swing means for Bayer’s crop science and chemical costs Global equity volatility and swings in commodities are…

Cashu Finance·9 months ago

Commodity and Energy Volatility Pressures Bayer AG’s Crop‑Science Inputs and Supply‑Chain Funding

Market volatility touches commodity and energy markets Global risk swings are transmitting into commodity and energy markets, testing input-cost dynamics for large agrochemical and pharmaceutical firm…

Cashu Finance·10 months ago

Commodities Shock and Credit Squeeze Tighten Bayer AG Margins

Commodities shock tightens margins for Bayer’s crop and chemical operations Volatility in commodities and credit markets is putting renewed pressure on input costs and supply-chain financing for large…

Cashu Finance·10 months ago

Bayer AG's Stock Rises with Supreme Court Appeal on Roundup Litigation Amid Trade Tensions

Bayer AG Positioned for Legal Victory Amid Trade Tensions Bayer AG is currently experiencing a positive shift in its stock performance following the US Supreme Court's decision to hear its appeal conc…

Cashu Finance·10 months ago

Bayer AG Gains Legal Ground in Roundup Appeal Amid Trade Tensions

Bayer AG's Legal Momentum in Roundup Litigation Amid Trade Tensions Bayer AG experiences a notable uptick in share prices as the US Supreme Court agrees to hear its appeal concerning the ongoing Round…

Cashu Finance·10 months ago

Bayer AG Gains Stock Momentum with Supreme Court Appeal on Roundup Litigation

Bayer AG Secures Legal Momentum Amidst Trade Tensions In a significant legal development, Bayer AG experiences a notable increase in its stock value following the US Supreme Court's decision to hear t…

Cashu Finance·10 months ago

Bayer AG's AskBio Advances Gene Therapy for Late-Onset Pompe Disease with FDA Approval

Bayer AG Advances Gene Therapy Efforts with FDA Acceptance for Pompe Disease Treatment Bayer AG's wholly owned subsidiary, AskBio Inc., marks a pivotal moment in gene therapy development with the rece…

Cashu Finance·10 months ago

Bayer AG's AskBio Receives IND for Gene Therapy AB-1009 Targeting Pompe Disease

Bayer AG Advances Gene Therapy for Pompe Disease with IND Acceptance Bayer AG's wholly owned subsidiary, AskBio Inc., celebrates a pivotal achievement with the acceptance of its Investigational New Dr…

Cashu Finance·10 months ago

Bayer AG's AskBio Advances Gene Therapy for Pompe Disease with FDA IND Approval

Bayer AG Advances Gene Therapy for Pompe Disease with IND Acceptance Bayer AG's subsidiary, AskBio Inc., marks a significant achievement in the realm of gene therapy with the recent acceptance of its…

Cashu Finance·10 months ago

Bayer AG's Critical Role in the Debate on Sustainable Industrial Agriculture Practices

Bayer AG's Role in the Industrial Agriculture Debate: A Critical Examination Bayer AG stands at the crossroads of modern agricultural practices and the growing criticism surrounding industrial farming…

Cashu Finance·10 months ago

Bayer AG Partners with Cradle to Advance Drug Development Using AI Technology

Bayer Partners with Cradle to Enhance Drug Development Through AI Bayer AG has entered into a strategic three-year collaboration with Cradle, a company renowned for its advancements in scientific AI s…

Cashu Finance·10 months ago

Bayer AG Enhances Drug Discovery Through AI Partnership with Cradle

Bayer AG Expands AI Capabilities with Strategic Partnership Bayer AG has forged a significant three-year collaboration with Cradle, a company at the forefront of scientific AI software specializing in…

Cashu Finance·11 months ago

Bayer AG Leads in siRNA Therapeutics for Innovative Disease Treatment Solutions

Bayer AG's Strategic Focus on siRNA Therapeutics Bayer AG is making significant strides in the field of small interfering RNA (siRNA) therapeutics, positioning itself as a leader in this rapidly evolv…

Cashu Finance·11 months ago

Bayer AG Leads in siRNA Therapeutics, Transforming Nucleic Acid-Based Medical Treatments

Bayer AG Advances Nucleic Acid Therapeutics: A Focus on siRNA Technology Bayer AG solidifies its position as a frontrunner in the biopharmaceutical industry through its commitment to developing small…

Cashu Finance·11 months ago

Bayer AG Under Fire for Glyphosate Research Integrity Amid Retraction Controversy

Bayer AG Faces Scrutiny Over Glyphosate Research Integrity In recent developments, Bayer AG contends with mounting scrutiny over the integrity of academic research related to its controversial herbici…

Cashu Finance·12 months ago

Bayer AG and IBM Revolutionize Football Analytics with AI and Cloud Technology

Bayer AG and IBM’s Game-Changing Partnership in Football Analytics Bayer AG, through its collaboration with IBM, is transforming the landscape of professional football analytics. The partnership focus…

Cashu Finance·12 months ago

Bayer AG Defends Roundup Amid Legal Struggles and Regulatory Challenges

Bayer Defends Roundup Amid Legal Challenges and Regulatory Scrutiny Bayer AG's CEO Bill Anderson stands firm in defending the safety profile of Roundup, a widely used herbicide that has come under int…

Cashu Finance·12 months ago

Bayer AG's Asundexian Shows Promise for Stroke Prevention in Phase 3 Study

Bayer AG Advances Stroke Prevention with Promising Phase 3 Study Results Bayer AG announces significant findings from its Phase 3 OCEANIC-STROKE study, evaluating asundexian, an investigational oral F…

Cashu Finance·12 months ago

Bayer AG's Asundexian Shows Promise in Stroke Prevention Study Results

Bayer AG Advances Stroke Prevention with Promising Phase 3 Study Results Bayer AG announces significant topline results from its Phase 3 OCEANIC-STROKE study, focusing on its investigational oral FXIa…

Cashu Finance·12 months ago

Bayer AG Advances R&D with TetraScience's AI-Driven Data Integration Solutions

Bayer AG Enhances R&D Capabilities Through Advanced Data Integration Bayer AG is taking significant strides in revolutionizing its pharmaceutical and crop science research and development (R&D) operat…

Cashu Finance·12 months ago

Bayer AG Reports Strong Earnings Growth Through Strategic Initiatives and Innovation Efforts

Bayer AG Reports Strong Earnings Growth Amid Strategic Initiatives Bayer AG announces a significant increase in its financial performance, reporting adjusted earnings of 17 cents per American Deposita…

Cashu Finance·1 year ago

Bayer AG Strengthens Partnership with Ginkgo Bioworks for Sustainable Agricultural Innovations

Bayer Expands Collaboration with Ginkgo Bioworks to Innovate Agricultural Solutions Bayer AG deepens its strategic partnership with Ginkgo Bioworks, a collaboration that commenced in 2017, with a rene…

Cashu Finance·1 year ago

Bayer AG Strengthens Partnership with Ginkgo Bioworks for Sustainable Agricultural Innovations

Bayer AG Expands Agricultural Biologicals Partnership with Ginkgo Bioworks Bayer AG's ongoing collaboration with Ginkgo Bioworks signifies a progressive step in the agricultural sector as they deepen…

Cashu Finance·1 year ago

Bayer AG Embraces AI to Revolutionize Healthcare and Agriculture Solutions

Bayer AG Eyes AI Innovations to Transform Healthcare Solutions Bayer AG is at the forefront of leveraging artificial intelligence (AI) to enhance its healthcare offerings. As the AI sector experiences…

Cashu Finance·1 year ago

Bayer AG Partners with Subtle Medical to Innovate MRI Imaging and Enhance Patient Safety

Bayer AG Embraces Innovation in Radiology through Collaboration with Subtle Medical Bayer AG continues to strengthen its commitment to advancing medical imaging through its collaboration with Subtle M…

Cashu Finance·1 year ago

Bayer AG Partners with Subtle Medical for AI-Enhanced MRI Imaging Innovations

Bayer and Subtle Medical Forge Ahead in AI-Enhanced MRI Imaging Bayer AG collaborates with Subtle Medical, Inc. in a groundbreaking study that showcases the potential of artificial intelligence (AI) i…

Cashu Finance·1 year ago

Bayer AG Partners with WHO Foundation to Tackle Neglected Tropical Diseases and Climate Health.

Bayer and WHO Foundation Forge Partnership to Combat Neglected Tropical Diseases In a significant development for global health, Bayer AG collaborates with the WHO Foundation to enhance health initiat…

Cashu Finance·1 year ago

Bayer AG Collaborates with WHO Foundation to Tackle Neglected Tropical Diseases and Promote Self-Care

Bayer AG Partners with WHO Foundation to Combat Neglected Tropical Diseases Bayer AG has formalized a significant partnership with the WHO Foundation, aimed at enhancing global health initiatives, par…

Cashu Finance·1 year ago

Bayer AG to Showcase Innovations in Life Sciences at Veeva Commercial Summit 2025

Bayer AG at the Veeva Commercial Summit: Driving Innovation in Life Sciences Bayer AG is set to play a pivotal role at the upcoming Veeva Commercial Summit in Madrid, Spain, scheduled for November 5-6…

Cashu Finance·1 year ago

Bayer AG Leads Innovative Customer Engagement at Veeva Commercial Summit 2025

Innovative Advancements in Customer Engagement: Bayer AG at the Veeva Commercial Summit Bayer AG is set to play a pivotal role at the upcoming Veeva Commercial Summit, scheduled for November 5-6, 2025…

Cashu Finance·1 year ago

Bayer AG Partners with Mint Pharmaceuticals to Enhance Access to ADALAT® XL® in Canada

Bayer AG Enhances Patient Access to Essential Medication Through Strategic Partnership Bayer AG partners with Mint Pharmaceuticals Inc. to distribute ADALAT® XL® (nifedipine extended-release tablets)…

Cashu Finance·1 year ago

Bayer AG Positioned for Growth in $2.1 Billion Contrast Media Injector Market

Bayer AG's Strategic Positioning in the Growing Contrast Media Injector Market Bayer AG, a global leader in life sciences, stands to benefit significantly from the anticipated growth in the contrast m…

Cashu Finance·1 year ago

Corteva's Restructuring Signals Shift in Agriculture; Bayer AG Must Adapt to Market Trends

Corteva's Strategic Restructuring: A Shift in Agriculture Dynamics Corteva Inc., a leading player in the agriculture industry, is currently assessing a significant restructuring plan aimed at separati…

Cashu Finance·1 year ago

Corteva's Restructuring: Impacts on Bayer AG and the Agricultural Sector

Corteva's Strategic Restructuring: Implications for the Agricultural Sector Corteva Inc., a significant player in the agricultural industry, is reportedly on the brink of a major restructuring that wo…

Cashu Finance·1 year ago

Bayer AG Launches Radiology Development Centre in India for Innovative Healthcare Solutions

Bayer Strengthens Radiology Innovation with New Development Centre in India Bayer AG, a leading global company in healthcare and life sciences, partners with Tata Elxsi to inaugurate the Bayer Develop…

Cashu Finance·1 year ago

Bayer AG Empowers Women Entrepreneurs to Combat Food Security and Health Issues Globally

Bayer Foundation Champions Women Entrepreneurs to Tackle Global Food Security and Health Challenges In a significant move to support women-led initiatives addressing critical global issues, the Bayer…

Cashu Finance·1 year ago

Bayer AG Foundation Empowers Women Entrepreneurs to Tackle Global Healthcare and Food Security Challenges

Bayer Foundation Champions Women Entrepreneurs Tackling Global Challenges The Bayer Foundation Women Entrepreneurs Award (BFWEA) for 2025 recognizes 15 remarkable women from diverse regions, including…

Cashu Finance·1 year ago

Bayer AG Partners with Kumquat to Develop KRAS G12D Cancer Treatment

Bayer Partners with Kumquat Biosciences to Target KRAS G12D Mutations in Cancer Treatment Bayer AG has entered into a significant collaboration with Kumquat Biosciences Inc. to develop a novel KRAS G1…

Cashu Finance·over 1 year ago

Bayer AG Partners with Kumquat to Develop KRAS G12D Cancer Treatment Inhibitor

Bayer and Kumquat Forge Alliance to Combat KRAS G12D Mutations in Cancer Treatment Bayer AG and Kumquat Biosciences Inc. are partnering to develop a groundbreaking KRAS G12D inhibitor, aimed at addres…

Cashu Finance·over 1 year ago

Bayer AG Faces Scrutiny Over Pesticide Liability Act and Food Safety Concerns

Concerns Grow Over Pesticide Liability Protection Act's Impact on Food Safety As Congress deliberates the Pesticide Liability Protection Act, significant concerns arise regarding its potential to jeop…

Cashu Finance·over 1 year ago

Bayer AG Collaborates with K36 Therapeutics on Clinical Development of KTX-2001 for Cancer Treatment

K36 Therapeutics Initiates Clinical Development for KTX-2001 in Partnership with Bayer K36 Therapeutics, Inc. heralds a significant advancement in cancer treatment with the U.S. Food and Drug Administ…

Cashu Finance·over 1 year ago

Bayer AG Collaborates with K36 Therapeutics on KTX-2001 Phase 1 Trial for Prostate Cancer

K36 Therapeutics Initiates Phase 1 Trial for KTX-2001 in Collaboration with Bayer K36 Therapeutics, Inc., a clinical-stage biotechnology firm, advances its mission to tackle unmet needs in cancer trea…

Cashu Finance·over 1 year ago

Bayer AG's Commitment to Innovative Cancer Therapies in Evolving Oncology Landscape

Bayer AG's Oncology Strategy: The Importance of Innovative Cancer Therapies Bayer AG finds itself in a rapidly evolving oncology landscape, where advancements in cancer therapies are crucial for patie…

Cashu Finance·over 1 year ago